NOXICARE

Manufacturer
Truceuticals, LLC
Effective date
2012-12-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:04:18

Label at a glance#

ProductNOXICARE Natural Pain Relief
Active ingredient.Alpha.-Lipoic Acid, Turmeric, Ocimum Tenuiflorum Top, Indian Frankincense, Rosemary, Salix Alba Bark, Ginger
Label structure10 sections

Indications and uses

Temporary relief of pain associated with: Joint and Muscle Inflammation Nerve damage Fitness and Sports Injuries

Dosage and administration

Adults: Take one capsule 2-3 times daily with or without food. Children: Ask a doctor before use if under 18 years of age.

Storage and handling

Bottle contains tamper-evident seal under cap. Store at 20-25°C (68-77°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active Ingredients (in each capsule):Purpose
"HPUS" is an abbreviation for Homeopathic Pharmacopoeia of the United States
Alpha-lipoic ac 1x HPUS (alpha-lipoic acid)Antioxidant
Curcuma longa 1x (Turmeric extract)Anti-inflammatory
Ocimum sanc 1x HPUS (Holy basil extract)Anti-inflammatory
Olibanum 1x HPUS (Boswellia extract)Anti-inflammatory
Rosmarinus 1x HPUS (Rosemary extract)Analgesic
Salix Alba 1x HPUS (White willow extract)Anti-inflammatory
Zingiber 1x HPUS (Ginger extract)Anti-inflammatory

Uses

INDICATIONS & USAGE SECTION

Temporary relief of pain associated with:

  • Joint and Muscle Inflammation
  • Nerve damage
  • Fitness and Sports Injuries

Warnings

WARNINGS SECTION

OTC - ASK DOCTOR SECTION

  • If symptoms persist or worsen, consult a physician.
  • Ask a doctor before use if under 18 years of age.

OTC - PREGNANCY OR BREAST FEEDING SECTION

  • If pregnant or nursing ask a healthcare professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults: Take one capsule 2-3 times daily with or without food. Children: Ask a doctor before use if under 18 years of age.

Other Information

STORAGE AND HANDLING SECTION

Bottle contains tamper-evident seal under cap. Store at 20-25°C (68-77°F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Vegetarian capsule (hypromellose, water)

QUESTIONS & COMMENTS

OTC - QUESTIONS SECTION

877-NOXICARE

SPL UNCLASSIFIED SECTION

Manufactured in USA for Truceuticals® Inc.
5530 Wisconsin Avenue, Suite 1550
Chevy Chase, MD 20815

PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NOXICARE™

Natural
PAIN RELIEF
capsules

Formulated by
Reza Ghorbani, MD
ABIPP, FIPP

Joint Pain

Muscle Pain

Nerve Pain

60 Capsules

PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Carton
PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51230-824-602019-11-27C16284748780-19855d018-ea1d-cd31-e053-dbdaa90ab51aNOXICARE™ Natural Pain Relief

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51230-824-60NOXICARE Natural Pain Relief60 in 1 BOTTLECAPSULE601
51230-824-60NOXICARE Natural Pain Relief1 in 1 CARTONCAPSULE11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51230-824NOXICARE NATURAL PAIN RELIEF (.ALPHA.-LIPOIC ACID, TURMERIC, OCIMUM TENUIFLORUM TOP, INDIAN FRANKINCENSE, ROSEMARY, SALIX ALBA BARK, AND GINGER) CAPSULE [TRUCEUTICALS, LLC]1Legacy NDC, 2 package rows20130208_313a8be3-37f7-4e4f-aa24-04e031e4bb79.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
.Alpha.-Lipoic AcidACTIVE INGREDIENT73Y7P0K73Y1
GingerACTIVE INGREDIENTC5529G5JPQ1
Indian FrankincenseACTIVE INGREDIENT4PW41QCO2M1
Ocimum Tenuiflorum TopACTIVE INGREDIENT34T63W8ULS1
RosemaryACTIVE INGREDIENTIJ67X351P91
Salix Alba BarkACTIVE INGREDIENT205MXS71H71
TurmericACTIVE INGREDIENT856YO1Z64F1
.Alpha.-Lipoic AcidACTIVE MOIETY73Y7P0K73Y1
GingerACTIVE MOIETYC5529G5JPQ1
Indian FrankincenseACTIVE MOIETY4PW41QCO2M1
Ocimum Tenuiflorum TopACTIVE MOIETY34T63W8ULS1
RosemaryACTIVE MOIETYIJ67X351P91
Salix Alba BarkACTIVE MOIETY205MXS71H71
TurmericACTIVE MOIETY856YO1Z64F1
HypromellosesINACTIVE INGREDIENT3NXW29V3WO1
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51230-82451230-824-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 27 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, ORALLY DISINTEGRATING / ORAL41 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, FILM COATED / ORAL582 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOINSERT / VAGINAL54.21 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, EXTENDED RELEASE / ORAL1472 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOGRANULE / ORAL45 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSHAMPOO / TOPICAL3 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOJELLY / TOPICALNAExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, FILM COATED, EXTENDED RELEASE / ORAL221 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOGEL / RECTAL348 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, DELAYED RELEASE / ORAL79 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE / ORAL1488 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE, COATED PELLETS / ORAL3.32 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, COATED / ORAL58 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSYSTEM / TOPICAL54 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSYRUP / ORAL250 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOLOTION / TOPICAL0.1 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET, CHEWABLE / ORAL11.8 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCREAM / TOPICAL0.1 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOGRANULE, FOR SUSPENSION / ORAL1.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOSUSPENSION / ORAL305 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE, EXTENDED RELEASE / ORAL119.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE, DELAYED RELEASE / ORAL105 mgExact identifier — unii candidate
27 equally ranked IID candidates
HypromellosesHYPROMELLOSE3NXW29V3WOTABLET / ORAL1127 mgExact identifier — unii candidate
27 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ddafa3ab-c669-4a06-87be-0d31f16d6ce4313a8be3-37f7-4e4f-aa24-04e031e4bb792012-12-20WarningsExact identifier
spl id: ddafa3ab-c669-4a06-87be-0d31f16d6ce4
spl set id: 313a8be3-37f7-4e4f-aa24-04e031e4bb79

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.